Quantitative Systematic Strategies’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,236
Closed -$248K 300
2019
Q4
$248K Buy
1,236
+243
+24% +$49.9K 0.04% 474
2019
Q3
$210K Buy
+993
New +$207K 0.05% 400
2018
Q2
Sell
-3,203
Closed -$518K 645
2018
Q1
$518K Buy
+3,203
New +$510K 0.11% 304
2017
Q4
Sell
-2,346
Closed -$318K 563
2017
Q3
$318K Sell
2,346
-8,312
-78% -$1.05M 0.08% 321
2017
Q2
$1.33M Buy
+10,658
New +$1.27M 0.34% 113
2017
Q1
Sell
-7,180
Closed -$830K 370
2016
Q4
$830K Sell
7,180
-3,651
-34% -$406K 0.34% 140
2016
Q3
$1.13M Buy
10,831
+138
+1% +$14.4K 0.42% 84
2016
Q2
$1.03M Buy
+10,693
New +$1.01M 0.48% 37
2016
Q1
Sell
-5,318
Closed -$486K 478
2015
Q4
$486K Buy
5,318
+1,330
+33% +$125K 0.13% 189
2015
Q3
$370K Sell
3,988
-4,583
-53% -$436K 0.18% 255
2015
Q2
$791K Buy
8,571
+4,081
+91% +$381K 0.18% 194
2015
Q1
$426K Buy
+4,490
New +$416K 0.12% 237
2014
Q3
Sell
-5,273
Closed -$371K 321
2014
Q2
$371K Buy
5,273
+1,690
+47% +$119K 0.27% 148
2014
Q1
$265K Buy
+3,583
New +$270K 0.22% 204

Other funds holding CME

Quantitative Systematic Strategies's CME Position: Q1 2020 in Review

Quantitative Systematic Strategies sold out of CME Group (CME) in Q1 2020, closing a stake of 1,236 shares — an estimated $248K sold.

Quantitative Systematic Strategies first reported a position in CME in Q1 2014 and held it in 14 quarters. The position peaked at $1.33M in Q2 2017. 1,029 funds tracked by Wall St. Rank hold CME as of Q1 2020.

  • Quantitative Systematic Strategies reported no remaining CME Group position as of Q1 2020 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 1,236 CME Group shares in Q1 2020, an estimated $248K.
  • Quantitative Systematic Strategies first reported a position in CME Group in Q1 2014 and held it in 14 quarters.
  • Quantitative Systematic Strategies's CME Group position peaked at $1.33M in Q2 2017.
  • 1,029 funds tracked by Wall St. Rank held CME Group as of Q1 2020.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2020, filed 6 May 2020.